Company intelligence / Profile preview

Emerging Technology Partners

South San Francisco, California, United Statesetpvc.com ↗

Ownership: Private
Development stage: Other

Overview

Emerging Technology Partners is a life sciences-focused venture capital firm investing in innovative diagnostic and therapeutic product companies across the US and China. Their portfolio includes early-stage to post-IPO investments in areas such as precision oncology and longevity. They support strategic alliances for their portfolio companies but do not themselves develop drugs or clinical programs.

Therapeutic areas: OncologyOther
Modalities: Small moleculeBiologicMonoclonal antibodyGene therapy
Industry: Investors

Partnerships

Co-investments with Pivotal bioVenture Partners ChinaSinovation VenturesTriwise Capital ManagementStrategic alliances facilitated for portfolio companies globally

Beyond the preview

Go deeper on Emerging Technology Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emerging Technology Partners.

Explore the full profile